Medicine News and Research

RSS

MGH, Veridex establish research center of excellence on circulating tumor cell technologies

Massachusetts General Hospital (MGH) has entered into a collaborative agreement with Veridex LLC to establish a center of excellence in research on circulating tumor cell (CTC) technologies. The overall goal of the agreement is to develop and commercialize novel technologies for capturing and characterizing CTCs, solid tumor cells found at extremely low levels in the bloodstream, which may offer a key to noninvasive characterization of cancer and potentially to early detection.

4 Jan 2011

CDK1 protein deactivates EZH2 enzyme that causes cancer spread

By sticking a chemical group to it at a specific site, a protein arrests an enzyme that may worsen and spread cancer, an international research team led by scientists at The University of Texas MD Anderson Cancer Center reports in the January issue of Nature Cell Biology.

4 Jan 2011

Embryome Sciences announces $4M equity financing, changes name to ReCyte Therapeutics

BioTime, Inc. today announced a $4 million equity financing by its subsidiary, Embryome Sciences, Inc. Concurrent with the financing, Embryome Sciences will be renamed ReCyte Therapeutics, Inc. and will develop therapeutic products for cardiovascular and blood diseases. The new equity financing is being led by a $2.5 million investment by private investors and a $1.5 million investment from BioTime that valued ReCyte Therapeutics at a post money valuation of $60 million on a fully diluted basis.

4 Jan 2011

18F-FDG PET scans help evaluate cognitive dysfunction of pediatric fever-induced epilepsy

Sudden, catastrophic childhood epilepsy is a parent's worst nightmare, especially in the case of fever-induced refractory epileptic encephalopathy in school-age children (FIRES). While not much is known about the condition, new research published in the January issue of The Journal of Nuclear Medicine shows that positron emission tomography (PET) scans can offer an evaluation of cognitive dysfunction of FIRES, its evolution and further prognosis.

4 Jan 2011

Researchers report estrogen may increase movement of precancerous cells in oral cavity

Head and neck cancer is the sixth most common type of cancer and is on the rise in some demographic groups, including young women without any known risk factors. Now, researchers at Fox Chase Cancer Center report that estrogen may increase the movement of precancerous cells in the mouth and thus promote the spread of the disease within the oral cavity.

4 Jan 2011

U-M research shows children are more frequently exposed to radiation through imaging tests

Children frequently exposed to medical imaging procedures that utilize radiation, U-M research shows. "Our findings indicate that more awareness about the frequent use of these tests may be needed among care providers, hospitals and parents," says Adam L. Dorfman, M.D., clinical assistant professor of pediatrics and communicable diseases and of radiology at the U-M Medical School.

4 Jan 2011

Risk-adjusted TTR appears to improve anticoagulation control

Researchers from Boston University School of Medicine and the Bedford VA Medical Center believe that risk-adjusted percent time in therapeutic range should be used as part of an effort to improve anticoagulation control and thus improve patient outcomes.

4 Jan 2011

Researchers identify new biological pathway that contribute to glaucoma

In a study published today in the Proceedings of the National Academy of Sciences, a team of researchers from the Kennedy Krieger Institute and four collaborating institutions, identified a new and unexpected biological pathway that appears to contribute to the development of glaucoma and its resulting vision loss.

4 Jan 2011

Los Angeles Magazine declares LA BioMed physicians as 2011 Southern California Super Doctors

A select 40 physician-researchers at Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center were named 2011 Southern California Super Doctors in the January issue of Los Angeles Magazine.

4 Jan 2011

VIP program appears to promote parent-child interactions in families with low socioeconomic status

Parent education programs delivered through pediatric primary care offices appeared to increase parent-child interactions during infancy in at-risk families, according to a report in the January issue of Archives of Pediatrics & Adolescent Medicine, one of the JAMA/Archives journals.

4 Jan 2011

Fondation Leducq awards Penn Medicine researcher $6M grant for cardiovascular disease study

An international team of researchers led by Daniel J. Rader, MD, associate director of Penn Medicine's Institute for Translational Medicine and Therapeutics, has received a $6 million grant from the Paris-based Fondation Leducq to study the molecular genetics of atherosclerotic cardiovascular disease. The team's proposal, "Molecular Mechanisms of Novel Genes Associated with Plasma Lipids and Cardiovascular Disease," was selected to receive the award through the Fondation's Transatlantic Networks of Excellence Program.

4 Jan 2011

New ATS guidelines for treating fungal infection in adult pulmonary and critical care patients

The American Thoracic Society has released a new official clinical policy statement on the treatment of fungal infections in adult pulmonary and critical care patients.

4 Jan 2011

C. difficile infection has become common among hospitalized children in the US

Hospitalized children in the United States are more frequently becoming infected with the bacteria Clostridium difficile, according to a report posted online today that will appear in the May print issue of Archives of Pediatrics & Adolescent Medicine, one of the JAMA/Archives journals.

3 Jan 2011

Flu worries continue

The flu season continues to affect more people. Experts have warned the Britons are still at risk as the surge in flu cases has still not yet peaked. The cases would increase they warn, over the next two to four weeks. World Health Organization released figures that show the rate of influenza-like illnesses is still low across continental Europe but has risen dramatically in Britain since the flu season began in October.

3 Jan 2011

Deceptive food labels lead to increased risk of deadly diseases

Did you know that when you pick up a product promoted as trans fat free, you may still be ingesting a significant amount of this potentially harmful substance? An article by Case Western Reserve University School of Medicine student Eric Brandt, published in the January/February 2011 issue of the American Journal of Health Promotion, reveals that misleading labeling practices can result in medically significant intake of harmful trans fat, despite what you read on Food and Drug Administration (FDA) approved labels.

3 Jan 2011

FDA authorizes Juventas' JVS-100 Phase II clinical trial for critical limb ischemia

Juventas Therapeutics, a clinical-stage regenerative medicine company developing novel therapies for cardiovascular disease, announces that the U.S. Food and Drug Administration (FDA) authorized commencement of a Phase II clinical trial evaluating the efficacy and safety of its lead product, JVS-100, for the treatment of critical limb ischemia (CLI).

3 Jan 2011

Today's Opinions: End-of-life counseling; Rising costs of boomers; Controlling infections in hospitals

Death panels. Government-sponsored euthanasia. Pulling the plug on grandma. Those were just some of the blatantly false terms conservatives threw around last year to scare Congress into stripping a provision out of the health-reform bill that would have allowed Medicare to reimburse doctors for providing voluntary, end-of-life counseling to their patients. The scare tactics worked (1/2).

3 Jan 2011

FDA clears ACT's IND to treat AMD using hESC derived RPE cells

Advanced Cell Technology, Inc., a leader in the field of regenerative medicine, announced today that the US Food and Drug Administration (FDA) has cleared the Company's Investigational New Drug (IND) application to treat Dry Age-Related Macular Degeneration (AMD) using retinal pigment epithelial (RPE) cells derived from human embryonic stem cells (hESCs).

3 Jan 2011

Saint John's Health System and St.Vincent Jennings parter with Indiana Health Information Exchange

Joining a network that includes 19,000 physicians and over 80 hospitals, long-term care facilities and other healthcare organizations, Saint John's Health System and St.Vincent Jennings Hospitals are now part of the Indiana Health Information Exchange (IHIE). The two hospitals are now connected through their participation in IHIE's DOCS4DOCS ® Service.

3 Jan 2011

MEDNAX acquires Neonatal Medical Associates

MEDNAX, Inc., today announced the acquisition of a neonatal physician group in Long Beach, CA.

3 Jan 2011

Medicine News and Research

MGH, Veridex establish research center of excellence on circulating tumor cell technologies

CDK1 protein deactivates EZH2 enzyme that causes cancer spread

Embryome Sciences announces $4M equity financing, changes name to ReCyte Therapeutics

18F-FDG PET scans help evaluate cognitive dysfunction of pediatric fever-induced epilepsy

Researchers report estrogen may increase movement of precancerous cells in oral cavity

U-M research shows children are more frequently exposed to radiation through imaging tests

Risk-adjusted TTR appears to improve anticoagulation control

Researchers identify new biological pathway that contribute to glaucoma

Los Angeles Magazine declares LA BioMed physicians as 2011 Southern California Super Doctors

VIP program appears to promote parent-child interactions in families with low socioeconomic status

Fondation Leducq awards Penn Medicine researcher $6M grant for cardiovascular disease study

New ATS guidelines for treating fungal infection in adult pulmonary and critical care patients

C. difficile infection has become common among hospitalized children in the US

Flu worries continue

Deceptive food labels lead to increased risk of deadly diseases

FDA authorizes Juventas' JVS-100 Phase II clinical trial for critical limb ischemia

Today's Opinions: End-of-life counseling; Rising costs of boomers; Controlling infections in hospitals

FDA clears ACT's IND to treat AMD using hESC derived RPE cells

Saint John's Health System and St.Vincent Jennings parter with Indiana Health Information Exchange

MEDNAX acquires Neonatal Medical Associates

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News